EP0675723A4 - BIPHOSPHONATE / ESTROGEN THERAPY FOR TREATING AND PREVENTING BONE LOSS. - Google Patents

BIPHOSPHONATE / ESTROGEN THERAPY FOR TREATING AND PREVENTING BONE LOSS.

Info

Publication number
EP0675723A4
EP0675723A4 EP94905419A EP94905419A EP0675723A4 EP 0675723 A4 EP0675723 A4 EP 0675723A4 EP 94905419 A EP94905419 A EP 94905419A EP 94905419 A EP94905419 A EP 94905419A EP 0675723 A4 EP0675723 A4 EP 0675723A4
Authority
EP
European Patent Office
Prior art keywords
biphosphonate
treating
bone loss
preventing bone
estrogen therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP94905419A
Other languages
German (de)
French (fr)
Other versions
EP0675723A1 (en
Inventor
Donna T Whiteford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0675723A1 publication Critical patent/EP0675723A1/en
Publication of EP0675723A4 publication Critical patent/EP0675723A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP94905419A 1992-12-23 1993-12-17 BIPHOSPHONATE / ESTROGEN THERAPY FOR TREATING AND PREVENTING BONE LOSS. Ceased EP0675723A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99641892A 1992-12-23 1992-12-23
US996418 1992-12-23
PCT/US1993/012302 WO1994014455A1 (en) 1992-12-23 1993-12-17 Bisphosphonate/estrogen therapy for treating and preventing bone loss

Publications (2)

Publication Number Publication Date
EP0675723A1 EP0675723A1 (en) 1995-10-11
EP0675723A4 true EP0675723A4 (en) 1998-08-05

Family

ID=25542895

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94905419A Ceased EP0675723A4 (en) 1992-12-23 1993-12-17 BIPHOSPHONATE / ESTROGEN THERAPY FOR TREATING AND PREVENTING BONE LOSS.

Country Status (5)

Country Link
EP (1) EP0675723A4 (en)
JP (1) JPH08505142A (en)
AU (1) AU5953894A (en)
CA (1) CA2151240A1 (en)
WO (1) WO1994014455A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ287984B6 (en) * 1993-05-15 2001-03-14 Roche Diagnostics Gmbh Tablet with enhanced biological availability of active substance i.e. clodronic acid and process for preparing thereof
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
UA41909C2 (en) * 1994-07-22 2001-10-15 Елі Ліллі Енд Компані Use A combination of compounds for the inhibition of osteoporosis, a pharmaceutical agent
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
JPH10506638A (en) * 1995-05-12 1998-06-30 メルク エンド カンパニー インコーポレーテッド Prevention of tooth loss by administration of alendronate or its salt
US5545635A (en) * 1995-05-23 1996-08-13 Eli Lilly And Company Inhibiting bone loss with equilenin
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy
IL120265A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists
IL120270A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to treat osteoporosis
EP1378234A1 (en) * 1996-05-17 2004-01-07 MERCK & CO. INC. Effervescent bisphosphonate formulation
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
DE69726879T2 (en) * 1996-05-17 2004-10-14 Merck & Co., Inc. BIPHOSPHONATE FORMULATION WITH EFFECT
US6376477B2 (en) 1996-11-25 2002-04-23 Merck & Co., Inc. Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism
WO1998023274A1 (en) * 1996-11-25 1998-06-04 Merck & Co., Inc. Androgenic and bisphosphonic agents coadministered to treat diseases
DE19719680A1 (en) * 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Use of diphosphonic acids for the preventive treatment of long-term consequences of bladder enlargement or replacement
EP0998934A4 (en) * 1997-12-25 2005-09-14 Toray Industries Remedies for intramedullary diseases
CN1173704C (en) 1998-12-04 2004-11-03 罗什诊断学股份有限公司 Application of ibanzoate in promoting osseointegration of endoprosthesis
EP1210138A4 (en) * 1999-04-22 2003-05-07 Hydro Med Sciences Inc Controlled delivery of bisphosphonates
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
FR2803521B1 (en) 2000-01-12 2002-10-25 Ceva Sante Animale USE OF TILUDRONIC ACID AND ITS DERIVATIVES IN POULTRY FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR PREVENTING AND TREATING OSTEOPOROSIS
DE60143964D1 (en) * 2001-02-06 2011-03-10 Sydney Children S Hospitals Network Randwick And Westmead Incorporating The Royal Alexandra Hospital DRUGS TO TREAT OSTEONE COSMETICS AND TO SUPPLY PATIENTS WITH RISK TO OSTEONE CRYOSIS
NZ528659A (en) * 2001-04-03 2005-02-25 Royal Alexandra Hosp Children A drug for use in bone grafting
AUPR553701A0 (en) * 2001-06-07 2001-07-12 Royal Alexandra Hospital For Children, The A device for the delivery of a drug to a fractured bone
TWI315982B (en) 2001-07-19 2009-10-21 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
EA006053B1 (en) 2001-12-24 2005-08-25 Тева Фармасьютикал Индастриес Лтд. A solid dosage form, process for making therefor and tooling
US7488496B2 (en) 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
EP1508343B1 (en) * 2003-08-21 2015-11-04 AddBIO AB Bisphosponate coated implant device and method therefor
EP1940339B1 (en) * 2005-10-27 2011-12-21 Thommen Medical Ag Dental implant and production method for said implant
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005187A1 (en) * 1990-09-18 1992-04-02 Boehringer Mannheim Gmbh NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
WO1992014474A1 (en) * 1991-02-26 1992-09-03 Norwich Eaton Pharmaceuticals, Inc. Methods for the treatment of osteoporosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (en) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh NEW DIPHOSPHONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005187A1 (en) * 1990-09-18 1992-04-02 Boehringer Mannheim Gmbh NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
WO1992014474A1 (en) * 1991-02-26 1992-09-03 Norwich Eaton Pharmaceuticals, Inc. Methods for the treatment of osteoporosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CIMINERA N. ET AL: "Studio Comparativo degli effeti di estrogeni e difosfonati sulla perdita ossea postmenopausale", ANN. OSTET. GINECOL. MED. PERINAT., vol. 113, no. 5, 1992, pages 232 - 237, XP002064831 *
See also references of WO9414455A1 *

Also Published As

Publication number Publication date
WO1994014455A1 (en) 1994-07-07
AU5953894A (en) 1994-07-19
JPH08505142A (en) 1996-06-04
EP0675723A1 (en) 1995-10-11
CA2151240A1 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
DE69739758D1 (en) VACCINE FOR THE TREATMENT OF LYMPHOMA AND LEUKEMIA
EP1079741A4 (en) IMPLANTABLE TISSUE CLOSURE AND SYSTEM FOR TREATING GASTROESOPHAGIC REFLOW
DE69312624D1 (en) DEVICE FOR DISTINATING TACHYCARDIA AND FIBRILLATIONS AND FOR THE TREATMENT THEREOF
ATA11989A (en) AGENTS FOR PREVENTING AND TREATING PERIODONTOPATHIES
DE69525473D1 (en) DEVICE FOR TREATING BLOOD VESSELS
DE69730604D1 (en) OXADIC ACIDS AND RELATED COMPOUNDS FOR TREATING SKIN DISORDER
DE69524682D1 (en) Treatments for wounds
DE59410094D1 (en) DEVICE FOR TREATING BIOLOGICAL TISSUE AND BODY CONCERMENTS
EP0651633A4 (en) PHOSPHOPEPTIDE FOR TREATMENT.
DE69018457D1 (en) OBJECTS FOR TREATING PERIODONTITIS AND BONE DEFECTS.
DE69427869D1 (en) BOTULINUMTOXINS FOR TREATING HYPERHYDROSIS
ATA76995A (en) STABLE PREPARATION FOR TREATING BLOOD COIST DISORDERS
EP0709090A3 (en) Compositions for the treatment of resistant tumors
DE69526684D1 (en) Aeration mixer for the treatment of molten metal
DE69112480D1 (en) Method and device for treating medical waste.
DE69318693D1 (en) Magnetic conditioner for the treatment of liquids
DE69220051D1 (en) Grain treatment device
DE69817862D1 (en) NARINGIN AND NARINGENIN AS A MEDICINE FOR PREVENTING OR TREATING LIVER DISEASES
DE69421196D1 (en) DEVICE FOR TREATING OVERBIT
DE69527140D1 (en) ACTIVE SUBSTANCE FOR PREVENTING OR TREATING OSTEOPOROSIS
DE69506019D1 (en) Pain treatment device
DE69729004D1 (en) PHOTODYNAMIC THERAPY FOR TREATING OSTEOSRTHRITIS
DE69727240D1 (en) COMBINATIONS CONTAINING VX478, ZIDOVUDIN AND 3TC FOR THE TREATMENT OF HIV
DE59501606D1 (en) DEVICE FOR TREATING PCBS
ZA931778B (en) Method and composition for the treatment of osteoporosis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950724

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19980619

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19981008

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20031106

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1009249

Country of ref document: HK